Section one: Contracting authority/entity
one.1) Name, addresses and contact point(s)
Ministry of Defence
Chemical Biological Radiological Nuclear (CBRN) Delivery Team, Yew 3A, #1342 MOD Abbey Wood
Bristol
BS34 8JH
For the attention of
Lewis Dale
Email(s)
Country
United Kingdom
Internet address(es)
General address of the contracting authority/entity
one.2) Type of the contracting authority
Ministry or any other national or federal authority, including their regional or local subdivisions
one.3) Main activity
Defence
Section two: Object of the contract
two.1) Description
two.1.1) Title attributed to the contract
SUPPLY OF BOTULISM ANTITOXIN HEPTEVALENT (HBAT)
two.1.2) Type of contract and location of works, place of delivery or of performance
Supplies
Purchase
NUTS code
- CA - Canada
two.1.4) Short description of the contract or purchase(s)
The Chemical, Biological, Radiological and Nuclear (CBRN) team, part of Defence Equipment and Support (DE&S) organisation within the UK Ministry of Defence (MOD), has placed a contract with Emergent Biosolutions Canada Inc for the supply of Heptavalent Botulism Antitoxin (HBAT) for a period of 3 years. This is necessary to ensure maintenance of the capability with an acceptable stockholding level.
two.1.5) Common procurement vocabulary (CPV)
- 33651520 - Immunoglobulins
two.2) Total final value of contract(s)
two.2.1) Total final value of contract(s)
Value: £4,318,485.45
Excluding VAT
Section four: Procedure
Type of procedure
Negotiated without publication of a contract notice
Justification for the award of the contract without prior publication of a contract notice
1) Justification for the choice of the negotiated procedure without prior publication of a contract notice
No tenders or no suitable tenders in response to: negotiated procedure competition
The works/goods/services can be provided only by a particular tenderer for reasons that are:
technical
It is considered that this contract can be awarded using the negotiated procedure without prior publication of a contract notice, pursuant to Public Contracts Regulations 2015; where “Regulation 32 (2)(b)(ii) allows you to use the Negotiated procedure without Prior Publication when the exclusivity is due to technical reasons”. Summary of the Technical Reason: Emergent Biosolutions Canada Inc are currently the only licensed manufacturer for HBAT (BAT®) which provides antitoxin serotypes A-G for treatment of Botulism worldwide. This product is therefore the only product which provides the full capability to Defence.
four.2) Award criteria
four.2.1) Award criteria
Lowest price
four.2.2) Information about electronic auction
An electronic auction has been used: no
four.3) Administrative information
four.3.1) File reference number attributed by the contracting authority
CBRN/00272
four.3.2) Previous publication(s) concerning the same contract
Voluntary ex ante transparency notice
Notice number: 2022/S 000-016860 of 20 June 2022
Section five: Award of contract
Contract No
CBRN/00272
five.1) Date of contract award decision
13 April 2023
five.2) Information about offers
Number of offers received
1
Number of offers received by electronic means
1
five.3) Name and address of economic operator in favour of whom the contract award decision has been taken
Emergent BioSolutions Canada Inc.
155 Innovation Dr
Winnipeg
R3T 5Y3
Country
Canada
five.4) Information on value of contract
Total final value of the contract
Value: £4,318,485.45
Excluding VAT
If annual or monthly value
Number of years: 3
five.5) Information about subcontracting
The contract is likely to be sub-contracted: No
Section six: Complementary information
six.1) Information about European Union funds
The contract is related to a project and/or programme financed by European Union funds: No
six.3) Procedures for appeal
six.3.1) Body responsible for appeal procedures
Ministry of Defence
Bristol
Country
United Kingdom